Abstract:High‐fat diet feeding enhances DNMTs' mRNA and protein expression via increasing chromatin accessibility and decreasing ubiquitination‐mediated protein degradation, resulting in hypermethylation at the Klb promoter and subsequent downregulation of Klb expression; this in turn impairs fatty acid oxidation and oxidative phosphorylation and promotes the development of hepatic steatosis in mice. While extensive investigations have been devoted to the study of genetic pathways related to fatty liver diseases, much less is known about epigenetic mechanisms underlying these disorders. DNA methylation is an epigenetic link between environmental factors (e.g., diets) and complex diseases (e.g., non‐alcoholic fatty liver disease). Here, it is aimed to study the role of DNA methylation in the regulation of hepatic lipid metabolism. A dynamic change in the DNA methylome in the liver of high‐fat diet (HFD)‐fed mice is discovered, including a marked increase in DNA methylation at the promoter of Beta‐klotho (Klb), a co‐receptor for the biological functions of fibroblast growth factor (FGF)15/19 and FGF21. DNA methyltransferases (DNMT) 1 and 3A mediate HFD‐induced methylation at the Klb promoter. Notably, HFD enhances DNMT1 protein stability via a ubiquitination‐mediated mechanism. Liver‐specific deletion of Dnmt1 or 3a increases Klb expression and ameliorates HFD‐induced hepatic steatosis. Single‐nucleus RNA sequencing analysis reveals pathways involved in fatty acid oxidation in Dnmt1‐deficient hepatocytes. Targeted demethylation at the Klb promoter increases Klb expression and fatty acid oxidation, resulting in decreased hepatic lipid accumulation. Up‐regulation of methyltransferases by HFD may induce hypermethylation of the Klb promoter and subsequent down‐regulation of Klb expression, resulting in the development of hepatic steatosis.

Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease

Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease

Deciphering the role of aberrant DNA methylation in NAFLD and NASH

Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis

Research on the Function of Epigenetic Regulation in the Inflammation of Non-Alcoholic Fatty Liver Disease

Update on Genetics and Epigenetics in Metabolic Associated Fatty Liver Disease

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease

The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement

Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation

Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease

Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD

Microbial Metabolites: Critical Regulators in NAFLD

Whole-genome DNA Methylation and Gene Expression Profiling in the Livers of Mice with Nonalcoholic Steatohepatitis.

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Dietary Pattern's Role in Hepatic Epigenetic and Dietary Recommendations for the Prevention of NAFLD

Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease

The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease

What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?